Neonatal Nursing Symposium 2026

Thursday, May 14, 2026, 7:15 AM - 4:30 PM, CHOP- HUB building


This one-day program will provide neonatal nurses with innovative therapies in the neonatal intensive care unit. This educational offering boasts information on a variety of complex physiological and developmental neonatal issues. Research and technology are consistently expanding, and this program will review some of the latest therapies used to care for sick neonates.

1. Identify best practices for caring for the ELBW infants.
2. Describe uses of Artificial Intelligence in healthcare and the NICU.
3. Describe pathophysiology of Chronic Lung Disease and the care of CLD patients.
4. Recognize best practices for Hydrotherapy in the NICU.
5. Describe strategies for supporting families in the NICU.
6. Identify best practices for unique diagnosis and therapies in the NICU, including Progressive Mobility, Ventilation Strategies, HIE & Cooling, and Surgical Diagnoses.

In support of improving patient care, Children’s Hospital of Philadelphia is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ANCC NCPD Contact Hours (13.30 hours)

Course attendees should make their own hotel reservations early by calling one of the hotels listed
below. These hotels are within walking distance of Children’s Hospital of Philadelphia:

The Study at University City
20 S 33rd Street
Philadelphia, PA 19104
215-387-1400

Sheraton Philadelphia University City Hotel
36th and Chestnut Streets
Philadelphia, PA 19104
215-387-8000

The Inn at Penn
3600 Sansom Street
Philadelphia, PA 19104
215-222-0200

Mitigation of Relevant Financial Relationships

Children's Hospital of Philadelphia adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, May 14, 2026

SHARE YOUR KNOWLEDGE AND EXPERTISE

The course directors and planning committee invite you to submit an abstract for consideration for the poster session held during the conference. Share your knowledge and expertise related to current concepts in neonatal care. Research in process or previously presented posters are welcome.

SUBMISSION DEADLINE EXTENDED: Wednesday, April 1, 2026 (11:59 pm EST)

ACCEPTANCE NOTIFICATION DATE: Friday, April 17, 2026

Accepted abstracts will be published in the conference syllabus. To learn more and submit an abstract, go to chop.cloud-cme.com.

Please use this link to submit your abstract.

CLICK HERE TO SUBMIT ABSTRACTS

2026 Abstract Submission Guidelines

Types of abstracts that will be accepted:

Case Reports

Quality Improvement

Educational Outcomes

Clinical Research

Work that previously presented at local, national, or international meetings will be considered for presentation; however, material that has been published as a manuscript in a peer-reviewed journal will not be considered.

Important Considerations Regarding Abstract Submission:

• The following are required for first authors and contributing authors.

                        -First name, Last name, Degree, Organization, Email

            *Please identify the corresponding author and provide telephone number and preferred email address.

• Abstracts must be submitted electronically.

                        -You will have the opportunity to review, edit and finish abstract submission as often as you like, until the date when submissions are closed.

• Abstract must total no more than 500 words.

• Once you have submitted your abstract, you will be directed to complete a financial disclosure form.

                        -Non-commercial product names must be used wherever possible. All off-label or non-FDA approved use must be disclosed.

                        -Failure to comply with the abstract submission requirements may result in withdrawal of the abstract for consideration by the program committee and possible suspension from future meeting presentations.

• Abstracts selected as poster presentations will be displayed in-person on Thursday May 14, 2026.

• Poster presenters are responsible for their own course registration fees.

 

Abstracts for this activity are closed.